Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
163 |
|
| Actual shortage: | 6 (4%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 5 (3%) | |
| Resolved: | 151 (93%) | |
Discontinuation Reports |
53 |
|
| To be discontinued: | 1 (2%) | |
| Discontinued: | 52 (98%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (16%) |
|
Overdue reports |
2 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AFINITOR | 7.5MG | TABLET | Resolved | 2018-05-24 | 2018-07-10 | 50215 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-06-01 | 2018-06-19 | 51063 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-06-22 | 2018-07-27 | 52770 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-08-15 | 2018-10-18 | 58228 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2020-04-20 | 2020-09-08 | 112537 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2022-09-29 | 2022-10-28 | 170488 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2024-01-24 | 2024-04-11 | 217088 |
| ARZERRA | 100MG | SOLUTION | Resolved | 2017-03-23 | 2018-10-17 | 4096 |
| ARZERRA | 1000MG | SOLUTION | Resolved | 2017-03-23 | 2018-09-27 | 4093 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-27 | 54440 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2020-02-04 | 2020-04-17 | 105259 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2018-04-27 | 2018-06-06 | 47338 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2018-11-23 | 2019-01-03 | 67490 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2020-02-21 | 2020-04-21 | 106958 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2020-03-31 | 2020-04-21 | 110235 |
| BETOPTIC S | 0.25% | SUSPENSION | Resolved | 2020-04-27 | 2020-05-21 | 113330 |
| BETOPTIC S | 0.25% | SUSPENSION | Resolved | 2020-05-21 | 2020-08-28 | 115462 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2018-09-28 | 2018-10-17 | 62545 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2022-09-14 | 2022-10-07 | 169228 |
| CILOXAN | 0.3% | OINTMENT | Resolved | 2019-02-11 | 2019-04-29 | 75343 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LOPRESOR 50MG | 50MG | TABLET | Discontinued | 2019-04-05 | 2019-04-05 | 80614 |
| LOPRESOR INJ 1.0MG/ML | 1MG | SOLUTION | Discontinued | 2019-04-05 | 2019-09-06 | 80607 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-06 | 2020-11-07 | 128052 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-06 | 2020-12-08 | 128056 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-26 | 2020-11-26 | 128967 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-06 | 2020-11-07 | 128059 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-06 | 2020-11-06 | 128062 |
| LOTENSIN 20MG | 20MG | TABLET | Discontinued | 2017-09-27 | 2018-08-29 | 23762 |
| LOTENSIN 5MG | 5MG | TABLET | Discontinued | 2017-07-10 | 2017-09-26 | 15053 |
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163678 |
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| RITALIN 10MG | 10MG | TABLET | Discontinued | 2022-02-08 | 2022-05-11 | 154449 |
| RITALIN 20MG | 20MG | TABLET | Discontinued | 2019-07-22 | 2019-08-01 | 89771 |
| RITALIN-SR TAB 20MG | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-02-08 | 2022-04-05 | 154439 |
| SANDOSTATIN | 200MCG | SOLUTION | Discontinued | 2022-02-08 | 2022-03-07 | 154429 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |
| SEBIVO | 600MG | TABLET | Discontinued | 2019-07-10 | 2019-11-06 | 89042 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| TEGRETOL CHEWTABS 100 MG | 100MG | TABLET (CHEWABLE) | Discontinued | 2017-09-27 | 2017-09-27 | 23765 |
| TEGRETOL CHEWTABS 200 MG | 200MG | TABLET | Discontinued | 2017-05-01 | 2017-06-06 | 8500 |